National HIV Testing Day, observed annually on June 27, serves as a critical prompt for individuals to know their HIV status through testing, which remains the cornerstone of prevention and treatment efforts. According to the Centers for Disease Control and Prevention (CDC), routine testing allows for early diagnosis and linkage to care, both of which are essential to improving health outcomes and reducing transmission rates.
Why is National HIV Testing Day important?
The primary goal of National HIV Testing Day is to reduce the stigma surrounding HIV and normalize testing as a routine part of preventative healthcare. Data from the CDC indicate that approximately 13% of people living with HIV in the United States are unaware of their status. Identifying these infections is the first step toward the "Ending the HIV Epidemic in the U.S." initiative, which aims to reduce new HIV infections by 90% by 2030. Knowing one’s status allows individuals to access life-saving antiretroviral therapy (ART), which, when taken as prescribed, can reduce the viral load to undetectable levels, effectively preventing transmission to sexual partners.
How have state policies expanded access to care?
State-level legislative efforts have significantly broadened the scope of who can provide HIV services. Many states have updated their pharmacy practice acts to allow pharmacists to initiate and furnish pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) without a direct prescription from a physician.
According to the National Alliance of State Pharmacy Associations, this shift reduces barriers to care by providing patients with more convenient access points in their local communities. By bypassing the need for a traditional doctor’s office visit, pharmacists act as a vital bridge, particularly in rural or underserved areas where access to primary care may be limited.
What are the latest advancements in HIV prevention?
The introduction of long-acting injectable therapies has transformed the landscape of HIV management and prevention.
- PrEP: The FDA has approved long-acting injectable cabotegravir (Apretude) for HIV pre-exposure prophylaxis. Unlike daily oral pills, this injectable option is administered every two months, which may improve adherence for patients who struggle with daily medication regimens.
- Treatment: For those living with HIV, long-acting regimens like cabotegravir and rilpivirine (Cabenuva) allow for monthly or bi-monthly injections, offering an alternative to daily oral antiretroviral therapy.
The HIV Medicine Association notes that while these therapies offer more flexibility, they require consistent clinical monitoring and adherence to the injection schedule to remain effective.
How to get tested for HIV
Testing is more accessible today than it has been in previous decades. Options include:
- Clinical Settings: Hospitals, urgent care clinics, and community health centers provide diagnostic testing.
- Pharmacy Testing: Many retail pharmacies now offer rapid testing services.
- At-Home Testing: The FDA has approved several rapid self-testing kits that can be purchased at pharmacies or provided through public health programs. These tests provide results in as little as 20 minutes.
The CDC’s "GetTested" locator remains the primary resource for individuals to find free, fast, and confidential testing sites based on their zip code.
Key Takeaways
- Routine Screening: The CDC recommends that everyone between the ages of 13 and 64 get tested for HIV at least once as part of routine health care.
- Undetectable Equals Untransmittable (U=U): People who take ART as prescribed and maintain an undetectable viral load cannot transmit HIV to their partners.
- Professional Roles: Pharmacists are increasingly authorized to prescribe PrEP and PEP, simplifying the path to preventative care.
- Modern Options: Long-acting injectables provide alternatives to daily oral medications for both prevention and treatment.
As medical technology advances and policy barriers continue to fall, the focus remains on ensuring that testing, prevention, and treatment are integrated into standard medical practice. Early detection through testing is the most effective tool currently available to manage HIV and protect public health.